ST has made several key recommendations to the Federal Government’s National Medicines Policy Review, to improve timely and affordable access to specialist medicines. Click to read full submission.
- Welcome to Specialised Therapeutics
-
SE Asia
+65 3158 9940
-
1300 798 820
-
New Zealand
+64 9801 0299
Submissions - Specialised Therapeutics
October 12, 2022
July 13, 2020
Transparency Reforms and Evaluation Support
Specialised Therapeutics Australia (STA) welcomes the opportunity to provide comments on the introduction of new measures to improve TGA transparency. STA was co-founded in 2008, with a commitment to commercialising specialist therapies and technologies that meet the unmet medical needs of all patients in its regions. Underpinning this endeavour is a foundation of innovation, which must be protected by regulatory transparency.
April 14, 2020
PBS Process Improvements Submission
By Carlo Montagner, CEO Specialised Therapeutics Australia Dear PBS Improvements Section, My name is Carlo Montagner and I am the Chief Executive Officer and co-founder of Australia’s largest independent pharmaceutical company, Specialised Therapeutics Australia (STA). We are a wholly family-owned Australian company, supplying specialist therapies and technologies to patients throughout Australia, as well as in